FDA aims for full approval of Pfizer COVID-19 vaccine by Labor Day: report

The U.S. Food and Drug Administration is aiming to grant full approval of the Pfizer-BioNTech coronavirus vaccine by Labor Day or sooner, according to a new report.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.